Bizarre Patents
Combination Beverage Container and Spittoon
A combination beverage container and spittoon includes a bottom portion including outer wall and a first inner wall defining a spittoon space.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8183254 | Inhibitors of JNK The invention relates to prodrugs of JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses prodrugs of JNK inhibitors, as described below in formula I: | 05/22/2012 |
| 8163906 | Dihydroquinone and dihydronaphthridine inhibitors of JNK Compounds of formula I are effective modulators of JNK: wherein X is CR11 or N; Y is —C(O)R3, 5-membered heteroaryl, or 5-membered heterocyclyl; | 04/24/2012 |
| 8163781 | Bi-aryl aminotetralines The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein R1-R5, A, B, Q, W, and X are defined in the detailed description and claims... | 04/24/2012 |
| 8163778 | Pyridines as FBPase inhibitors for treatment of diabetes Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof wherein the residues have the significance given in claim 1 and which can be used in the form of pharmaceutical compositions. | 04/24/2012 |
| 8158655 | Sulfonamide derivatives The invention is concerned with the novel sulfonamide derivatives of formula (I) wherein A, R1 to R2″, X and Y are as defined in the description and in the claims, as well as physiologically acceptab... | 04/17/2012 |
| 8153815 | Pseudoproline dipeptides Disclosed is a process for the manufacture of pseudo proline dipeptides of the formula wherein R1 is a side chain of an alpha amino acid, R2 is an amino protecting group and R3 and R4 | 04/10/2012 |
| 8143442 | Preparation for a cyclohexanecarboxylic acid derivative and intermediates A process for the preparation of a compound of formula (Ia): which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds. ... | 03/27/2012 |
| 8143422 | Benzimidazole derivatives The invention is concerned with novel benzimidazole derivatives of formula (I) wherein R1 to R6 are as defined in the description and in the claims, as well as physiologically acceptable salts and este... | 03/27/2012 |
| 8143280 | Glucocorticoid receptor antagonists The present invention relates to compounds of formula I wherein A, n, R1a to R1e and R2 to R5 are as defined in the description and claims, and pharmaceutically acceptable salts t... | 03/27/2012 |
| 8138208 | Aminotetrahydroindazoloacetic acids The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein Q, W, X, R1-R5 and n are defined in the detailed description and claims. In... | 03/20/2012 |
| 8129423 | Imidazolone and imidazoloidinone derivatives as 11b-HSD1 inhibitors Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositio... | 03/06/2012 |
| 8124641 | Aminotetrahydroindazoloacetic acids The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein Q, R1-R3 and n are defined in the detailed description and claims. In addition, the present inven... | 02/28/2012 |
| 8124636 | Imidazolidinone derivatives as 11B-HSD1 inhibitors Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein A and R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical composition... | 02/28/2012 |
| 8124629 | Naphthylacetic acids The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein X, Q, and R1-R6 are defined in the detailed description and claims. In addi... | 02/28/2012 |
| 8124604 | Inhibitors of bruton's tyrosine kinase This application discloses 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to generic Formulae I-IV: wherein, variables R, X, Y1, Y2, Y2′, Y3, Y | 02/28/2012 |
| 8119636 | Pyrrolopyrazine kinase inhibitors The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q and R are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-i... | 02/21/2012 |
| 8093385 | Leukotriene Binhibitors Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 01/10/2012 |
| 8093253 | Leukotriene Binhibitors Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 01/10/2012 |
| 8084262 | Biomarker for farnesyl pathway The invention generally provides methods to determine the extent to which a compound interferes with steroid metabolism, comprising a novel biomarker of a felinine derivative. The invention also provides such novel felinine derivative biomarker. ... | 12/27/2011 |
| 8076334 | Prodrugs of thyroid hormone analogs Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical composition... | 12/13/2011 |
| 8071628 | Indazole derivatives The invention is concerned with novel indazole derivatives of formula (I) wherein R1, R2, R3, R4, R5, R6, X and Y are as defined in the description and in th... | 12/06/2011 |
| 8039495 | Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 10/18/2011 |
| 8039493 | Biaryl sulfonamide derivatives The invention is concerned with novel biaryl sulfonamide derivatives of formula (I) wherein R1 to R3 and Y are as defined in the description and in the claims, as well as physiologically acceptable sal... | 10/18/2011 |
| 8039487 | Piperidine-amide derivatives The invention is concerned with novel piperidine-amide derivatives of formula (I) wherein R1, R2, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salt... | 10/18/2011 |
| 8030308 | Bicyclic sulfonamide derivatives which are L-CPT 1 inhibitors The invention is concerned with novel heterobicyclic derivatives of formula (I) wherein R1, R2, R3, R4, R5, R6, V, W, X and Y are as defined in the descripti... | 10/04/2011 |
| 8026365 | 4,4-disubstituted piperidine derivatives This invention relates to 4,4-disubstituted piperidine derivatives of the formula wherein A and R1 to R5 are as defined in the specification, and pharmaceutically acceptable salts thereof. The inventio... | 09/27/2011 |
| 8026345 | Characterization and identification of unique human adiponectin isoforms and antibodies The invention pertains to methods for measuring different forms of human adiponectin that are present in human plasma/serum, and more specifically methods are based on an ELISA assay that utilizes different monoclonal antibodies directed against adiponectin, in comb... | 09/27/2011 |
| 8026255 | Substituted piperidines as somatostatin receptor subtype 5 (SSTR5) antagonists This invention is concerned with compounds of the formula and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their prepara... | 09/27/2011 |
| 8017773 | Cyclohexyl sulfonamide derivatives The present invention relates to compounds of formula I wherein R1 to R3 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the tr... | 09/13/2011 |
| 8012974 | Pyrrolopyrazinyl urea kinase inhibitors The present invention relates to the use of novel pyrrolopyrazinyl urea derivatives of Formula I, wherein the variables R1, R2, R3, R4, and R5 are defined as described ... | 09/06/2011 |
| 8008505 | Indazole or 4,5,6,7-tetrahydro-indazole derivatives This invention relates to novel indazole or 4,5,6,7-tetrahydro-indazole derivatives of formula I wherein R1 to R8 are as defined in the description and in the claims, as well as physiologically accepta... | 08/30/2011 |
| 8008503 | Methyl-benzimidazole derivatives The invention is concerned with novel substituted benzimidazole derivatives of formula (I) wherein R1 to R10 are as defined in the description and in the claims, as well as physiologically acceptable s... | 08/30/2011 |
| 8008298 | Pyrrolopyrazine kinase inhibitors The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q1, R, and X are defined as described herein, which inhibit JAK and SYK and are useful for the tre... | 08/30/2011 |
| 7989657 | Anthranilic acid derivatives The invention is concerned with novel anthranilic acid derivatives of formula (I) wherein R1 to R14, m and n are as defined in the description and in the claims, as well as physiologically acceptable s... | 08/02/2011 |
| 7989454 | Leukotriene B4 inhibitors Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 08/02/2011 |
| 7977509 | Process for the preparation of acid halides A process for the preparation of acid halides of formula I which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds. ... | 07/12/2011 |
| 7973051 | Aminothiazoles as FBPase inhibitors for diabetes Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in claim 1 and which can be used in the form of pharmaceuti... | 07/05/2011 |
| 7968568 | Substituted piperidine derivatives as SST5 modulators This invention is concerned with compounds of the formula wherein A, R1 to R5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further re... | 06/28/2011 |
| 7964633 | Sulfonamide derivatives Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein L, R1, R2, m and n have the meaning given in claim 1 and which can be used in the form of pharma... | 06/21/2011 |
| 7956201 | Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one The present invention relates to a process of the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one of the formula by employing a dialkylmalonate of the formula wherein R... | 06/07/2011 |
